Volume : 13, Issue : 01, January – 2026
Title:
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR COACTIVATOR-1Α’S FUNCTION IN HEART ISCHEMIA
Authors :
Miss. Divyanshi Kushwah, Mr. Shashiranjan Yadav, Mr. Shivang Sharma
Abstract :
Cardiovascular disease remains one of the principle cause of death in both developed and developing countries. It may present as a typical myocardial infarction. Increase in cardiac workload impairs myocardial flow and when oxygen supply becomes inadequate to maintain the prevailing work load, relative ischemia develops and this condition is called Myocardial Infarction. Peroxisome proliferator-activated receptor coactivator-1α (PGC-1 α) is a master regulator of oxidative metabolism and mitochondrial function. PGC-1α lacks DNA-binding activity but interacts with nuclear receptors such as peroxisome proliferated activated receptors (PPARs) and co-activates numerous transcription factors like nuclear respiratory factors (NRFs) and estrogen related receptors (ERRs) that are involved in mitochondrial biogenesis, energy metabolism, fatty acid oxidation, antioxidant activity and angiogenesis.
Keywords: Myocardial Infarction, PGC-1 α, PPAR, NRF, ERR
Cite This Article:
Please cite this article in press Divyanshi Kushwah et al., Peroxisome Proliferator-Activated Receptor Coactivator-1α’s Function In Heart Ischemia, Indo Am. J. P. Sci, 2026; 13(01).
REFERENCES:
1. Arany, Z., He, H., Lin, J., Hoyer, K., Handschin, C., Toka, O., et al., (2005), “Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle,”Cell Metab., 1, pp. 259-27.
2. Carradori, S., Secci, D, Mai, A., “Epigenetic modulation of PGC-1α activity by GCN5 inhibitors: WO2010007085,” Expert Opin Ther Pat., 21(10), pp. 1651-1656.
3. Esterbauer, H., Oberkofler, H., Krempler, F., Patsch, W.,, “Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression,” Genomics., 62(1), pp. 98–102.
4. Goldenthal, MJ., Ananthakrishnan, R., Marín-García, J., “Nuclear-mitochondrial cross-talk in cardiomyocyte T3 signaling: A time-course analysis,”J Mol Cell Cardiol., 39, pp. 319–326.
5. Gundewar, S., Calvert, JW., Jha, S., Toedt-Pingel, Ji., Sy Nunez, D., et al., ,“Activation of Amp-Activated Protein Kinase By Metformin Improves Left Ventricular Function And Survival In Heart Failure,” Circ. Res., 104, pp. 403–441.
6. Han et al., “Myocardial ischaemic and diazoxide preconditioning both increase PGC-1alpha and reduce mitochondrial damage,”Acta Cardiol., 65(6), pp. 639-644.
7. Houtkooper, RH., Canto, C., Wanders, RJ., Auwerx, J., “The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways,” Endocr Rev., 31, pp. 194–223.
8. Hsieh, Y.C., Choudhry M.A., Yu, H.P., Shimizu, T., Yang, S., Suzuki, T., et al., “Inhibition of cardiac PGC-1alpha expression abolishes ER beta agonist-mediated cardioprotection following trauma–hemorrhage,” FASEB J., 20, 1109–1117.
9. Jager, S., et al., , “AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha Proc Natl Acad Sci U S A., 104, pp. 12017– 12022.Kim, JS., Jin, Y., Lemasters, JJ.,, “Reactive oxygen species but not Ca2+ overloading trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemiareperfusion,” Am J Physiol. Heart Circ. Physiol., 290, pp. 2024–2034
. 10. Lerin, C., Rodgers, JT., Kalume, DE., Kim, SH., Pandey, A., Puigserver, P.,,“GCN-5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1a,” Cell Metabolism., 3, pp .429–438.
11. Lopaschuk, GD., et al., “Myocardial fatty acid metabolism in health and disease,”Physiol Rev.90, pp. 207-258.
12. Orrenius, S., Zhivotovsky, B., Nicotera, P.,, “Regulation of cell death: the calciumapoptosis link,” Nat. Rev. Mol. Cell Biol., 4, pp. 552–565.
13. Rodgers, JT., Lerin, C., Haas, W., Gygi, SP., Spiegelman, BM., Puigserver, P., “Nutrient control of glucose homeostasis through a complex of PGC-1 alpha and SIRT1,” Nature., 434, pp. 113–118.
14. Rowe, GC., “PGC-1 coactivators in cardiac development and disease”, Circ. Res., 106, pp. 1559 –1569.
15. Tan W Q Wang K Lv D Y and Li P F , “Novel cardiac apoptotic pathway: the dephosphorylation of apoptosis repressor with caspase recruitment domain by calcineurin,”J Biol Chem., 283, pp. 29730–29739.
16. Villeneuve, CL., Guilbeau-Frugier, C., et al., , “p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A up-regulation: Role in chronic left ventricular dysfunction in mice,” Antioxid Redox Signal.,18,pp. 5–18.
17. Wellen, KE., Hatzivassiliou, G., Sachdeva, UM., Bui, TV., Cross, JR., Thompson, CB.,, “ATP-citrate lyase links cellular metabolism to histone acetylation,” Science., 324, pp. 1076–1080